Medication info
Omes Tablet 40 mg (Esomeprazole Magnesium Trihydrate)

Omes Tablet 40 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›44.5mg / 1 tablet
Manufacturer / importer
Samik Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets (14 tablets/Alu-Alu X 2, 7 tablets/Alu-Alu X 4)
Approval status
Active

MFDS item code 201507736 · Approved 2015.11.17 · Insurance code 644003700

Summary

Main use
Treatment and prevention of acid-related disorders (e.g., reflux) and ulcers; eradication therapy; relief of gastrointestinal symptoms caused by anti-inflammatory analgesics
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water; do not chew or crush it. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have been relieved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs, as-needed use is not recommended for controlling recurring symptoms. Administer this medicine 20 mg together with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies lasting more than 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The dose should thereafter be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg daily. Doses above 80 mg daily should be divided into 2 doses. After initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection, administer 40 mg once daily for 4 weeks. No dosage adjustment is necessary. Use with caution because there is limited experience in administering this medicine to patients with severe renal impairment. No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dosage adjustment is necessary.
Children's dosage
Adolescents 12 years of age and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents 12 years of age and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years of age and older — Once symptoms have been relieved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. Children under 12 years of age — There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
Samik Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of acid-related disorders (e.g., reflux) and ulcers; eradication therapy; relief of gastrointestinal symptoms caused by anti-inflammatory analgesics

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastric ulcer rebleeding
View approved original text

This medication is used for the treatment and symptom relief of gastroesophageal reflux disease, particularly erosive reflux esophagitis. It is also included in antibiotic combination therapy for the eradication and prevention of recurrence in patients with Helicobacter pylori-associated peptic ulcers. It helps alleviate upper gastrointestinal symptoms in patients taking non-steroidal anti-inflammatory drugs and treats and prevents gastric and duodenal ulcers. Additionally, it is effective in treating Zollinger-Ellison syndrome and for maintenance therapy following ulcer rebleeding. Overall, it is used for the treatment of various gastrointestinal-related diseases and symptom improvement.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water; do not chew or crush it. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have been relieved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs, as-needed use is not recommended for controlling recurring symptoms. Administer this medicine 20 mg together with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies lasting more than 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The dose should thereafter be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg daily. Doses above 80 mg daily should be divided into 2 doses. After initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection, administer 40 mg once daily for 4 weeks. No dosage adjustment is necessary. Use with caution because there is limited experience in administering this medicine to patients with severe renal impairment. No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dosage adjustment is necessary.

Children's dosage

Adolescents 12 years of age and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents 12 years of age and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years of age and older — Once symptoms have been relieved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. Children under 12 years of age — There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be used by certain patients. Patients who are hypersensitive to this medication or its components, or have a history of hypersensitivity to benzimidazole derivatives should not take it. Additionally, patients with hypersensitivity to penicillins or macrolide antibiotics should not be treated when combined with amoxicillin or clarithromycin for the eradication of Helicobacter pylori. Patients with a history of myocardial infarction or those who are breastfeeding should also avoid this medication. This medication can cause various adverse reactions. The most common symptoms include headache, abdominal pain, diarrhea, nausea, and vomiting, and dizziness or insomnia may occasionally occur. Rarely, blood abnormalities, hypomagnesemia, liver function abnormalities, skin rashes, and myalgia have been reported. In severe cases, serious side effects such as anaphylactic shock, Stevens-Johnson syndrome, and liver failure may occur, so if symptoms appear, immediate medical attention is required. Prolonged use may conceal symptoms of malignant tumors, so if weight loss, recurrent vomiting, or hematemesis occur, it is essential to consult a doctor. It is important to undergo regular examinations if taken for more than one year. This medication suppresses gastric acid, which may slightly increase the risk of diarrhea or gastrointestinal infections. This drug may interact with other medications, so caution is advised, especially when taking antiviral drugs, antibiotics, warfarin, methotrexate, clopidogrel, etc. The effects of drugs taken together with this medication may increase or decrease, so it is necessary to inform and consult with the doctor or pharmacist about all medications being taken. There is limited data on the safety of this drug during pregnancy, so pregnant women should consult a doctor before taking it, and breastfeeding women are advised not to take this medication. There is no specific antidote for overdose, so it is essential to visit a medical institution immediately for appropriate treatment, as this drug binds strongly to blood proteins and is not removed by dialysis. This medication should be kept out of the reach of children and care should be taken when transferring to another container as it may cause quality degradation or accidents.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbances, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized pustular psoriasis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, retrosternal pain, facial swelling, flushing, fatigue, fever, influenza-like symptoms, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, otalgia, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, muscle hypertonicity, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremor, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, shortness of breath, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, abnormal olfaction, taste loss, taste distortion, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, fundic gland polyps, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, asthenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is advisable to keep it at room temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain the drug's efficacy and prevents degradation.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alu X 2, 7 tablets/Alu-Alu X 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.